2-amino-6-trifluoromethoxy benzothiazole (PK 26124), a proposed antagonist of excitatory amino acid neurotransmission, does not produce phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys
dc.contributor.author | Koek, Wouter | en_US |
dc.contributor.author | Woods, James H. | en_US |
dc.date.accessioned | 2006-04-07T20:17:16Z | |
dc.date.available | 2006-04-07T20:17:16Z | |
dc.date.issued | 1988-07 | en_US |
dc.identifier.citation | Koek, W., Woods, J. H. (1988/07)."2-amino-6-trifluoromethoxy benzothiazole (PK 26124), a proposed antagonist of excitatory amino acid neurotransmission, does not produce phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys." Neuropharmacology 27(7): 771-775. <http://hdl.handle.net/2027.42/27255> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6T0C-479DMM1-7F/2/29029ae56c0a7f8ae250b554ea4dccf4 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/27255 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=2843787&dopt=citation | en_US |
dc.description.abstract | PK 26124, a proposed excitatory amino acid antagonist, was compared to mephenesin and phencyclldine (PCP).In pigeons, PK 26124 and mephenesin produced loss of righting that was to some extent associated with eye closure and muscle relaxation, whereas PCP produced catalepsy, i.e., loss of righting without eye closure and without muscle relaxation. PK 26124, but not nephenesin, produced PCP-like discriminative stimulus effects in some but not all pigeons.In rats, PK 26124 and mephenesin produced loss of righting but did not induce locomotion, sniffing, swaying and falling, unlike PCP.In rhesus monkeys, PK 26124 did not Induce ketamine-like discriminative stimulus effects.While PK 26124 may share some biochemical properties with excitatory amino acid antagonists these do not lead to behavioral effects similar to PCP. | en_US |
dc.format.extent | 468225 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | 2-amino-6-trifluoromethoxy benzothiazole (PK 26124), a proposed antagonist of excitatory amino acid neurotransmission, does not produce phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Psychiatry | en_US |
dc.subject.hlbsecondlevel | Neurosciences | en_US |
dc.subject.hlbsecondlevel | Chemistry | en_US |
dc.subject.hlbsecondlevel | Biological Chemistry | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Pharmacology (W.K., J.H.W.) and Department of Psychology (J.H.W.), M6322 Medical Science Building I, University of Michigan, Ann Arbor, Michigan, 48109, U.S.A. | en_US |
dc.contributor.affiliationum | Department of Pharmacology (W.K., J.H.W.) and Department of Psychology (J.H.W.), M6322 Medical Science Building I, University of Michigan, Ann Arbor, Michigan, 48109, U.S.A. | en_US |
dc.identifier.pmid | 2843787 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/27255/1/0000264.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0028-3908(88)90089-5 | en_US |
dc.identifier.source | Neuropharmacology | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.